91 related articles for article (PubMed ID: 2540515)
1. [Effect of angiotensin converting enzyme inhibitors on lipid, purine and glucose metabolism].
Buemi M; Frisina N
Recenti Prog Med; 1989 Feb; 80(2):78-82. PubMed ID: 2540515
[TBL] [Abstract][Full Text] [Related]
2. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
3. Effects of enalapril on lipid profile in diabetic and non-diabetic essential hypertensive patients.
Satia MC; Shukla ML; Goyal RK
Indian J Physiol Pharmacol; 1996 Jan; 40(1):83-6. PubMed ID: 8864777
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T; Lehtonen A
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
[TBL] [Abstract][Full Text] [Related]
5. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
Chazova IE; Mychka VB; Duishvili DE
Ter Arkh; 2004; 76(8):28-32. PubMed ID: 15471392
[TBL] [Abstract][Full Text] [Related]
6. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
Rahn KH
Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R
J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
[TBL] [Abstract][Full Text] [Related]
10. [Differential therapeutic topics in antihypertensive therapy. What can angiotensin-converting enzyme inhibitors accomplish?].
Noack E
Z Kardiol; 1988 Jul; 77(7):413-24. PubMed ID: 2850683
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular risk of diuretics in the treatment of arterial hypertension].
Hannedouche T
Nephrologie; 1987; 8(5):247-52. PubMed ID: 3328101
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
Modesti PA; Vanni S; Gensini GF
Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
16. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
18. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
Klaus D
Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with converting-enzyme inhibitors in hypertension.
Weber MA
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
[TBL] [Abstract][Full Text] [Related]
20. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
